© 2021 MJH Life Sciences™ and Contemporary OB/GYN. All rights reserved.
Volume 66 No 4: April 2021
Volume 66 No 4: April 2021
Economic impact of coverage expansion for NIPT
April 15, 2021
Expanding coverage for noninvasive prenatal testing (NIPT) through a performance-based, risk-sharing agreement (PBRSA) resulted in a significant increase in NIPT use, a significant decrease in conventional prenatal screening methods, and a negligible increase in per member per month (PMPM) cost at Harvard Pilgrim Health Care (HPHC) in New England.
FDA, CDC Recommend Temporary Pause for Johnson & Johnson COVID-19 Vaccine
April 14, 2021
The CDC and FDA will further investigate the reports of blood clots following administration of the vaccine.
Prevalence thresholds of screening tests
April 14, 2021
A literature review has found that the prevalence thresholds of various screening tests used in ob/gyn health care settings are significantly higher than the estimated disease prevalence.
AUGS Clinical Consensus Statement: Association of Anticholinergic Medication Use and Cognition in Women With Overactive Bladder
April 13, 2021
Overactive bladder affects a significant portion of the overall population and has substantial impact on daily activities and quality of life.
Were a Hysterectomy and a Bilateral Salpingo-oophorectomy Necessary?
April 13, 2021
This case illustrates how a clear explanation and empathy for the patient’s concerns may have avoided litigation altogether.